MedTrace Logo

AVANTAGE® RELOAD Double Mobility Acetabular Cup -Clinical Study

NCT03357445 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2024-11-14

No results posted yet for this study

Summary

This is a Post Marketing Clinical Follow Up study (PMCF) on the AVANTAGE RELOAD dual mobility system cup.

Conditions

  • Primary Osteoarthritis
  • Post-Traumatic Arthritis
  • Inflammatory Joint Disease
  • Femoral Neck Fracture
  • Femoral Head Necrosis
  • Sequelae From Previous Hip Surgery
  • Osteotomies
  • Congenital Hip Dysplasia

Interventions

OTHER

Avantage Reload cup

Patients receiving the Avantage Reload acetabular cup in total hip arthroplasty

Sponsors & Collaborators

  • Zimmer Biomet

    lead INDUSTRY

Principal Investigators

  • Hassan Achakri · Zimmer Biomet

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-10-14
Primary Completion
2027-04-27
Completion
2027-04-27

Countries

  • France
  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03357445 on ClinicalTrials.gov